135 related articles for article (PubMed ID: 32097747)
1. Gene interaction network studies to decipher the multi-drug resistance mechanism in Salmonella enterica serovar Typhi CT18 reveal potential drug targets.
Debroy R; Miryala SK; Naha A; Anbarasu A; Ramaiah S
Microb Pathog; 2020 Feb; 142():104096. PubMed ID: 32097747
[TBL] [Abstract][Full Text] [Related]
2. AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104.
Baucheron S; Tyler S; Boyd D; Mulvey MR; Chaslus-Dancla E; Cloeckaert A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3729-35. PubMed ID: 15388427
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
Wang-Kan X; RodrÃguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
[TBL] [Abstract][Full Text] [Related]
4. TolC dependency of multidrug efflux systems in Salmonella enterica serovar Typhimurium.
Horiyama T; Yamaguchi A; Nishino K
J Antimicrob Chemother; 2010 Jul; 65(7):1372-6. PubMed ID: 20495209
[TBL] [Abstract][Full Text] [Related]
5. The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host.
Webber MA; Bailey AM; Blair JM; Morgan E; Stevens MP; Hinton JC; Ivens A; Wain J; Piddock LJ
J Bacteriol; 2009 Jul; 191(13):4276-85. PubMed ID: 19411325
[TBL] [Abstract][Full Text] [Related]
6. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the Role of Two-Component Systems in Antibiotic Resistance Formation in Salmonella enterica Serovar Enteritidis.
Hu M; Huang X; Xu X; Zhang Z; He S; Zhu J; Liu H; Shi X
mSphere; 2022 Dec; 7(6):e0038322. PubMed ID: 36286534
[TBL] [Abstract][Full Text] [Related]
8. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18.
Rahman N; Muhammad I; Nayab GE; Khan H; Filosa R; Xiao J; Hassan STS
Curr Top Med Chem; 2019; 19(29):2708-2717. PubMed ID: 31702501
[TBL] [Abstract][Full Text] [Related]
9. In silico epitope identification of unique multidrug resistance proteins from Salmonella Typhi for vaccine development.
Jebastin T; Narayanan S
Comput Biol Chem; 2019 Feb; 78():74-80. PubMed ID: 30500555
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of RamA, Which Regulates Production of the Multidrug Resistance Efflux Pump AcrAB-TolC, Increases Mutation Rate and Influences Drug Resistance Phenotype.
Grimsey EM; Weston N; Ricci V; Stone JW; Piddock LJV
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988103
[TBL] [Abstract][Full Text] [Related]
11. Lack of AcrB Efflux Function Confers Loss of Virulence on
Wang-Kan X; Blair JMA; Chirullo B; Betts J; La Ragione RM; Ivens A; Ricci V; Opperman TJ; Piddock LJV
mBio; 2017 Jul; 8(4):. PubMed ID: 28720734
[TBL] [Abstract][Full Text] [Related]
12. Coordinated Expression of acrAB-tolC and Eight Other Functional Efflux Pumps Through Activating ramA and marA in Salmonella enterica serovar Typhimurium.
Zhang CZ; Chen PX; Yang L; Li W; Chang MX; Jiang HX
Microb Drug Resist; 2018 Mar; 24(2):120-125. PubMed ID: 28650690
[TBL] [Abstract][Full Text] [Related]
13. AcrA dependency of the AcrD efflux pump in Salmonella enterica serovar Typhimurium.
Yamasaki S; Nagasawa S; Hayashi-Nishino M; Yamaguchi A; Nishino K
J Antibiot (Tokyo); 2011 Jun; 64(6):433-7. PubMed ID: 21505470
[TBL] [Abstract][Full Text] [Related]
14. Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from
Alenazy R
Biology (Basel); 2022 Sep; 11(9):. PubMed ID: 36138807
[TBL] [Abstract][Full Text] [Related]
15. Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
Chen S; Cui S; McDermott PF; Zhao S; White DG; Paulsen I; Meng J
Antimicrob Agents Chemother; 2007 Feb; 51(2):535-42. PubMed ID: 17043131
[TBL] [Abstract][Full Text] [Related]
16. Potential of 1-(1-napthylmethyl)-piperazine, an efflux pump inhibitor against cadmium-induced multidrug resistance in Salmonella enterica serovar Typhi as an adjunct to antibiotics.
Kaur UJ; Chopra A; Preet S; Raj K; Kondepudi KK; Gupta V; Rishi P
Braz J Microbiol; 2021 Sep; 52(3):1303-1313. PubMed ID: 33851343
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the multidrug efflux transporter styMdtM from Salmonella enterica serovar Typhi.
Shaheen A; Ismat F; Iqbal M; Haque A; Ul-Haq Z; Mirza O; De Zorzi R; Walz T; Rahman M
Proteins; 2021 Sep; 89(9):1193-1204. PubMed ID: 33983672
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Resistance Mechanisms and Molecular Epidemiology of Fluoroquinolone-Nonsusceptible
Okanda T; Haque A; Ehara T; Huda Q; Ohkusu K; Miah RA; Matsumoto T
Microb Drug Resist; 2018 Dec; 24(10):1460-1465. PubMed ID: 29894282
[TBL] [Abstract][Full Text] [Related]
19. Deletion of
Hussain A; Ong EBB; Balaram P; Ismail A; Kien PK
Front Microbiol; 2023; 14():1301478. PubMed ID: 38029101
[TBL] [Abstract][Full Text] [Related]
20. Emergence of an Extensively Drug-Resistant
Klemm EJ; Shakoor S; Page AJ; Qamar FN; Judge K; Saeed DK; Wong VK; Dallman TJ; Nair S; Baker S; Shaheen G; Qureshi S; Yousafzai MT; Saleem MK; Hasan Z; Dougan G; Hasan R
mBio; 2018 Feb; 9(1):. PubMed ID: 29463654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
